Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06381102 · ClinicalTrials.gov registry record · NA
Transcutaneous Vagus Nerve Stimulation (taVNS) Dosage Study 1
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT06381102 is a NA study that has completed, run by University of Miami. The registered enrollment target is 31 participants.
The verdict
NCT06381102, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this research study is to investigate the effects of different forms of a gentle form of electrical stimulation applied to the ear, known as transcutaneous auricular vagus nerve stimulation (taVNS). The research team is interested in how the different forms affect comfort and tolerability, as well as how well it works.
Interventions
- DEVICE transcutaneous auricular vagus nerve stimulation 30/30
- DEVICE transcutaneous auricular vagus nerve stimulation 10/10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2024-04-13 |
| Est. Completion | 2024-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06381102
The ClinicalTrials.gov registry entry for NCT06381102 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which transcutaneous auricular vagus nerve stimulation 30/30 is the first listed.
NCT06381102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06381102 about?
NCT06381102 is a clinical study titled "Transcutaneous Vagus Nerve Stimulation (taVNS) Dosage Study 1". The purpose of this research study is to investigate the effects of different forms of a gentle form of electrical stimulation applied to the ear, known as transcutaneous auricular vagus nerve stimulation (taVNS). The research team is interested in how the different forms affect comfort and tolerabi...
What is the current status of trial NCT06381102?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2024-04-13. Estimated completion is 2024-10-01.
What interventions are being tested in trial NCT06381102?
The interventions under investigation include: transcutaneous auricular vagus nerve stimulation 30/30 (DEVICE), transcutaneous auricular vagus nerve stimulation 10/10 (DEVICE).
Who is sponsoring clinical trial NCT06381102?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.